SecSonar.com

Onconetix, Inc. (ONCO)

Onconetix, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Onconetix, Inc. (ONCO) is a Biotechnology company based in US with a market capitalization of $400.8K. Revenue declined 67.7% year-over-year and free cash flow was negative at -$9.7M. This page tracks ONCO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 12 employees · IPO Feb 18, 2022

Valuation

Valuation & price

$0.37 · as of May 17, 2026 · -99.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$246$123$0.95Jul 25Dec 25Jun 26Jul 7, 25$215.50Jul 9, 25$246.00Jul 11, 25$211.50Jul 15, 25$226.50Jul 17, 25$178.50Jul 21, 25$190.00Jul 23, 25$187.00Jul 25, 25$207.50Jul 29, 25$181.00Jul 31, 25$178.00Aug 4, 25$158.50Aug 6, 25$147.00Aug 8, 25$142.00Aug 12, 25$148.00Aug 14, 25$154.50Aug 19, 25$138.50Aug 21, 25$140.50Aug 25, 25$151.00Aug 27, 25$147.00Aug 29, 25$146.50Sep 3, 25$147.00Sep 5, 25$139.00Sep 9, 25$139.00Sep 11, 25$156.50Sep 15, 25$155.00Sep 17, 25$158.00Sep 19, 25$148.50Sep 23, 25$149.50Sep 25, 25$159.50Sep 29, 25$160.50Oct 2, 25$157.50Oct 6, 25$153.50Oct 8, 25$191.00Oct 10, 25$182.50Oct 14, 25$185.50Oct 16, 25$173.50Oct 20, 25$171.50Oct 22, 25$171.50Oct 24, 25$176.50Oct 28, 25$178.00Oct 30, 25$189.50Nov 3, 25$158.00Nov 5, 25$152.50Nov 7, 25$137.00Nov 11, 25$136.50Nov 14, 25$114.50Nov 18, 25$126.50Nov 20, 25$116.50Nov 24, 25$117.50Nov 26, 25$116.50Dec 1, 25$132.00Dec 3, 25$149.50Dec 5, 25$129.00Dec 9, 25$138.50Dec 11, 25$115.50Dec 15, 25$98.50Dec 17, 25$95.50Dec 19, 25$88.50Dec 23, 25$79.00Dec 26, 25$71.50Dec 31, 25$78.00Jan 5, 26$83.00Jan 7, 26$91.00Jan 9, 26$86.00Jan 13, 26$74.00Jan 15, 26$80.50Jan 20, 26$87.50Jan 22, 26$81.50Jan 26, 26$72.50Jan 28, 26$75.00Jan 30, 26$71.00Feb 3, 26$74.00Feb 5, 26$61.00Feb 9, 26$59.50Feb 11, 26$92.50Feb 17, 26$39.20Feb 19, 26$36.00Feb 23, 26$33.20Feb 25, 26$33.00Feb 27, 26$33.50Mar 3, 26$36.10Mar 5, 26$28.50Mar 9, 26$26.40Mar 11, 26$31.30Mar 13, 26$27.20Mar 17, 26$26.20Mar 19, 26$24.10Mar 23, 26$30.10Mar 25, 26$30.30Mar 27, 26$19.40Apr 1, 26$18.80Apr 6, 26$15.30Apr 8, 26$11.30Apr 10, 26$10.90Apr 14, 26$9.10Apr 16, 26$7.60Apr 20, 26$7.32Apr 22, 26$7.28Apr 24, 26$5.88Apr 28, 26$7.68Apr 30, 26$6.95May 4, 26$6.47May 6, 26$4.50May 8, 26$3.80May 12, 26$4.08May 15, 26$3.74May 19, 26$1.17May 21, 26$1.22May 26, 26$1.26May 28, 26$1.17Jun 1, 26$1.14Jun 3, 26$1.09Jun 5, 26$1.03Jun 9, 26$0.95Jun 11, 26$1.09Jun 15, 26$1.09Jun 17, 26$0.99Jun 22, 26$0.95Jun 24, 26$1.00Jun 30, 26$0.98
$0.9452-week range$246.00
Loading valuation history…

Fundamentals

Key fundamentals

$400.8K

Market cap

-67.7%

Revenue growth (YoY)

77.6%

Gross margin

-$9.7M

Free cash flow (USD)

-$5.2M

Net debt

Net cash position

2803.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$58.5KFY 2024$2.5MFY 2025$815.4K
$0$815.4K

Free cash flow by year

2019 → 2025

FY 2019$-829.6KFY 2020$-1.7MFY 2021$-2.0MFY 2022$-8.7MFY 2023$-13.6MFY 2024$-10.5MFY 2025$-9.7M
-$829.6K-$9.7M

Gross margin by year

2023 → 2025

FY 2023-1927.9%FY 202441.8%FY 202577.6%
-1927.9%77.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventReverse Stock SplitMay 19, 2026Filing
  • 8-K eventQ1 2026 Progress ReportMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventStockholder Meeting ResultsMay 4, 2026Filing
  • 8-K eventBoard Resignation and AppointmentApr 24, 2026Filing
  • Insider sellInsider Sell $34KHRT FINANCIAL LP · 10% Owner · $34.3KApr 22, 2026Filing
  • Insider sellInsider Sell $110KHRT FINANCIAL LP · 10% Owner · $110.2KApr 21, 2026Filing
  • Insider buyInsider Buy $128KHRT FINANCIAL LP · 10% Owner · $127.6KApr 16, 2026Filing

Questions

Frequently asked questions

What is Onconetix, Inc.'s market cap?

Onconetix, Inc. (ONCO) has a market capitalization of $400.8K.

What is ONCO's P/E ratio?

A meaningful P/E ratio is not available for ONCO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ONCO's price-to-book (P/B) ratio?

ONCO trades at 0.03 times book value per share.

Are insiders buying ONCO stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 2 sells at Onconetix, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

PPBT

Purple Biotech Ltd.

$396K

NXTS

N2OFF, Inc.

$333.3K

SPRC

SciSparc Ltd.

$523.4K

BDRX

Biodexa Pharmaceuticals Plc

$573.7K

JAGX

Jaguar Health, Inc.

$211.9K

SCNI

Scinai Immunotherapeutics Ltd.

$604.8K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.